Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 PandemicBatool A Haider, Dawn I. Velligan, Eric D. Achtyes et al.|Neuropsychiatric Disease and Treatment|2023Cited by 3
Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in SchizophreniaPeter J. Weiden, Dawn I. Velligan, Lauren Strand et al.|Neuropsychiatric Disease and Treatment|2025Cited by 1